Abstract:Mitochondria are the major source of energy for the normal functioning of brain cells. Increasing evidence suggests mitochondrial oxidative damage might be one of early events in Alzheimer's disease (AD) progression. Estrogen has been shown to suppress mitochondrial oxidative stress, regulate energy metabolism, and regulate the expression of mitochondria-involved anti-apoptotic proteins like bcl-2 family and bcl-xL, which suggests that brain mitochondria may be major targets of estrogen action in the central nervous system. Studies also demonstrated that many of these protective effects can be blocked by an estrogen receptor (ER) antagonist, ICI-182780, suggesting an ER-mediated mode of estrogen action. Even more interestingly, recent reports have confirmed the localization of ERb in the mitochondria and suggested that estrogen can directly affect mitochondrial function through mitochondrial ERb (mtERb). To address whether female AD brains exhibit mitochondrial impairment and whether it is correlated with estrogen receptors, we conducted mitochondrial functional analyses in female AD patients and age-matched non-demented (ND) individuals. Using frontal cortex samples from the brains of age-matched AD and non-ND women, we examined mitochondrial cytochrome C oxidase (COX) activity, and reactive oxygen species (ROS)-induced intracellular protein oxidation as protein carbonylation along with receptor-b (ERb) sub cellular distribution and protein expression. In order to investigate whether lacking of ERb causes mitochondrial dysfunction, mice with ERb gene knockout were used as an animal model. First, we found that the frontal cortices of female AD patients exhibited significantly reduced ERb expression, including in mitochondrial fraction, reduced mitochondrial COX activity, and increased protein carbonylation compared to the samples from ND. A significant linkage between the mitochondrial ERb expression and mitochondrial COX activity were observed in the female human brain, suggesting an involvement of ERb in mitochondrial function in the brain. Second, we noticed that mitochondria from the brains of ERb-knockout mice exhibited increased ROS generation and reduced mitochondrial membrane potential (MMP) under b-amyloid (Ab1-42 or Ab25-35) insult compared to brain mitochondria from wild-type control mice. These results suggest that ERb depletion can impair mitochondrial function in mice and may significantly contribute to the mitochondrial dysfunction involved in AD pathogenesis in women. Although further investigation is needed, our novel detection of ERb expression in neuronal mitochondria in the female human brain along with the direct correlation of mtERb expression with COX activity and the significant decrease of mtERb in the AD brain suggest a possible connection between ERb and mitochondrial dysfunction in AD. This hypothesis is supported by our experiments involving transgenic ERb knockout mice, which showed that ERb deficiency leads to mitochondrial dysfunction in the brain by decreasing MMP and by increasing mitochondrial vulnerability to Ab-induced ROS generation. Together, the results of this study indicate that ERb deficiency may play an important role in AD pathogenesis in females by contributing to mitochondrial dysfunction.

Estrogen Stimulates Degradation of Beta-Amyloid Peptide by Up-Regulating Neprilysin

Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.

Estrogen Regulation of the Neprilysin Gene Through A Hormone-Responsive Element

Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides

Estrogen Receptor Β Exerts Neuroprotective Effects by Fine-Tuning Mitochondrial Homeostasis Through NRF1/PGC-1α

Estrogen Lowers Alzheimer Β-Amyloid Generation by Stimulating Trans-Golgi Network Vesicle Biogenesis

Hormonal Control of Cerebral Amyloidogenesis in Alzheimer'S Diseases

Overexpression of Estrogen Receptor Beta Alleviates the Toxic Effects of Beta-Amyloid Protein on PC12 Cells Via Non-Hormonal Ligands

ERβ promotes Aβ degradation via the modulation of autophagy

The role of estrogen in Alzheimer's disease pathogenesis and therapeutic potential in women

Brain Endogenous Estrogen Levels Determine Responses to Estrogen Replacement Therapy via Regulation of BACE1 and NEP in Female Alzheimer’s Transgenic Mice

Neuroprotective Effect of Estrogen: Role of Nonsynaptic Nr2b-Containing Nmda Receptors

The role of estrogen in Alzheimer’s disease pathogenesis and therapeutic potential in women

Estrogen Receptor-Α is Localized to Neurofibrillary Tangles in Alzheimer's Disease.

Neuroprotective Effects of Estrogen on Beta‐Amyloid Induced Neurotoxicity in Murine Hypothalamic Cells

Testosterone Reduces Neuronal Secretion of Alzheimer'S Beta-Amyloid Peptides

ERβ mediates sex-specific protection in the App-NL-G-F mouse model of Alzheimer's disease

[Effects of Estrogen in the Central Nervous System].

Ginsenoside Rg3 Promotes Beta-Amyloid Peptide Degradation By Enhancing Gene Expression Of Neprilysin

P3‐182: Genetic Knockout of Estrogen Receptor‐ïβ¢ Contributes to Alzheimer's Disease Pathogenesis by Impairing Mitochondrial Function in Females

Estrogen Stimulates Release of Secreted Amyloid Precursor Protein from Primary Rat Cortical Neurons Via Protein Kinase C Pathway.